A recent incident at the former Pfizer headquarters in Midtown Manhattan, where two steel columns buckled during an office-to-residential conversion, has highlighted the inherent risks and complexities of these projects. The conversion, led by Nathan Berman's MetroLoft and David Werner, is one of New York City's most closely watched, aiming to deliver approximately 1,600 apartments. While no injuries were reported and the developer anticipates only a few weeks' delay, the event underscores the challenges of adapting decades-old office buildings for residential use, including structural reinforcements and redistributing building loads.
The incident occurred on the 21st floor of the newer of two buildings being converted. Initial analyses suggest that an 11-story addition to the shorter 1909 building overstressed the 37 floors below, leading to shifting and bending of supporting structures. The Department of Buildings has issued a vacate order, launched an investigation, and required a third-party forensic evaluation. Despite assurances from Berman, who called it a "freak accident," the event has prompted discussions about potential increases in engineering reviews, tighter underwriting, and additional contingency requirements, all of which could add time and cost to projects that often operate on thin margins.
New York City has actively encouraged office-to-residential conversions through expanded tax incentives and loosened zoning rules to address both high office vacancies and a housing shortage. Since 2020, 3.3 million square feet of office space have been converted to residential use, with more than 19 million square feet in the pipeline, according to Avison Young. The Pfizer project alone accounts for 1.3 million square feet of that pipeline. While Mayor Zohran Mamdani remains bullish on conversions as a solution to the housing crisis, he emphasized the need for safety and accountability, stating that the structural issues are not an inherent consequence of conversions but a breakdown in the process.
The economics of these conversions were already strained by elevated construction costs, expensive financing, and the complexities of retrofitting buildings not originally designed for residential living. A 2023 Moody’s Analytics study found that only 3% of city office buildings are structurally suitable for conversion, a fact gaining more attention after the Pfizer incident. This incident, impacting a project that is the largest office conversion in city history and intended to leverage a 2024 tax abatement for buildings with 25% affordable units, raises sharper questions about whether incentives are pushing marginal buildings into conversion too quickly.
